-
1
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
-
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345: 494-502.
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
Chrolavicius, S.4
Tognoni, G.5
Fox, K.K.6
-
2
-
-
20144373281
-
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
-
CLARITY-TIMI 28 Investigators
-
Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
-
(2005)
N Engl J Med
, vol.352
, pp. 1179-1189
-
-
Sabatine, M.S.1
Cannon, C.P.2
Gibson, C.M.3
Lopez-Sendon, J.L.4
Montalescot, G.5
Theroux, P.6
Claeys, M.J.7
Cools, F.8
Hill, K.A.9
Skene, A.M.10
McCabe, C.H.11
Braunwald, E.12
-
3
-
-
0037145863
-
Clopidogrel for the Reduction of Events during Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
CREDO Investigators
-
Steinhubl SR, Berger PB, Mann JT, III, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. J Am Med Assoc. 2002;288:2411-2420.
-
(2002)
J Am Med Assoc
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
Fry, E.T.4
Delago, A.5
Wilmer, C.6
Topol, E.J.7
-
4
-
-
33847149285
-
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
-
American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians
-
Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-818.
-
(2007)
Circulation
, vol.115
, pp. 813-818
-
-
Grines, C.L.1
Bonow, R.O.2
Casey Jr., D.E.3
Gardner, T.J.4
Lockhart, P.B.5
Moliterno, D.J.6
O'Gara, P.7
Whitlow, P.8
-
5
-
-
66349103930
-
Bedside evaluation of thienopyridine antiplatelet therapy
-
Price MJ. Bedside evaluation of thienopyridine antiplatelet therapy. Circulation. 2009;119:2625-2632.
-
(2009)
Circulation
, vol.119
, pp. 2625-2632
-
-
Price, M.J.1
-
6
-
-
33750429610
-
Platelet function assessment to predict outcomes after coronary interventions: Hype or hope?
-
Alfonso F, Angiolillo DJ. Platelet function assessment to predict outcomes after coronary interventions: hype or hope? J Am Coll Cardiol. 2006;48:1751-1754.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1751-1754
-
-
Alfonso, F.1
Angiolillo, D.J.2
-
7
-
-
18644372477
-
Structure and stereochemistry of the active metabolite of clopidogrel
-
Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab Dispos. 2002;30:1288-1295.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1288-1295
-
-
Pereillo, J.M.1
Maftouh, M.2
Andrieu, A.3
Uzabiaga, M.F.4
Fedeli, O.5
Savi, P.6
Pascal, M.7
Herbert, J.M.8
Maffrand, J.P.9
Picard, C.10
-
8
-
-
33646551868
-
Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers
-
Price MJ, Coleman JL, Steinhubl SR, Wong GB, Cannon CP, Teirstein PS. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers. Am J Cardiol. 2006;98:681-684.
-
(2006)
Am J Cardiol
, vol.98
, pp. 681-684
-
-
Price, M.J.1
Coleman, J.L.2
Steinhubl, S.R.3
Wong, G.B.4
Cannon, C.P.5
Teirstein, P.S.6
-
9
-
-
67649645191
-
Genetic variation of cyp2c19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
-
Varenhorst C, James S, Erlinge D, Brandt JT, Braun OO, Man M, Siegbahn A, Walker J, Wallentin L, Winters KJ, Close SL. Genetic variation of cyp2c19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease. Eur Heart J. 2009;30:1744-1752.
-
(2009)
Eur Heart J
, vol.30
, pp. 1744-1752
-
-
Varenhorst, C.1
James, S.2
Erlinge, D.3
Brandt, J.T.4
Braun, O.O.5
Man, M.6
Siegbahn, A.7
Walker, J.8
Wallentin, L.9
Winters, K.J.10
Close, S.L.11
-
10
-
-
58749094444
-
Cytochrome p-450 polymorphisms and response to clopidogrel
-
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360: 354-362.
-
(2009)
N Engl J Med
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
Shen, L.4
Hockett, R.D.5
Brandt, J.T.6
Walker, J.R.7
Antman, E.M.8
MacIas, W.9
Braunwald, E.10
Sabatine, M.S.11
-
11
-
-
58749090547
-
Genetic determinants of response to clopidogrel and cardiovascular events
-
French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
-
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Meneveau N, Steg PG, Ferrieres J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009;360:363-375.
-
(2009)
N Engl J Med
, vol.360
, pp. 363-375
-
-
Simon, T.1
Verstuyft, C.2
Mary-Krause, M.3
Quteineh, L.4
Drouet, E.5
Meneveau, N.6
Steg, P.G.7
Ferrieres, J.8
Danchin, N.9
Becquemont, L.10
-
12
-
-
58249135635
-
Cytochrome p450 2c19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
-
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G. Cytochrome p450 2c19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009;373:309-317.
-
(2009)
Lancet
, vol.373
, pp. 309-317
-
-
Collet, J.P.1
Hulot, J.S.2
Pena, A.3
Villard, E.4
Esteve, J.B.5
Silvain, J.6
Payot, L.7
Brugier, D.8
Cayla, G.9
Beygui, F.10
Bensimon, G.11
Funck-Brentano, C.12
Montalescot, G.13
-
13
-
-
69249219296
-
Association of cytochrome p450 2c19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA. Association of cytochrome p450 2c19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. J Am Med Assoc. 2009;302:849-857.
-
(2009)
J Am Med Assoc
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
O'Connell, J.R.2
Bliden, K.P.3
Gandhi, A.4
Ryan, K.5
Horenstein, R.B.6
Damcott, C.M.7
Pakyz, R.8
Tantry, U.S.9
Gibson, Q.10
Pollin, T.I.11
Post, W.12
Parsa, A.13
Mitchell, B.D.14
Faraday, N.15
Herzog, W.16
Gurbel, P.A.17
-
14
-
-
33845451677
-
A comparison of prasugrel and clopidogrel loading doses on platelet function: Magnitude of platelet inhibition is related to active metabolite formation
-
e9-e16
-
Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J. 2007;153:66.e9-e16.
-
(2007)
Am Heart J
, vol.153
, pp. 66
-
-
Brandt, J.T.1
Payne, C.D.2
Wiviott, S.D.3
Weerakkody, G.4
Farid, N.A.5
Small, D.S.6
Jakubowski, J.A.7
Naganuma, H.8
Winters, K.J.9
-
15
-
-
9644281093
-
The difference between clopidogrel responsiveness and posttreatment platelet reactivity
-
Samara WM, Bliden KP, Tantry US, Gurbel PA. The difference between clopidogrel responsiveness and posttreatment platelet reactivity. Thromb Res. 2005;115:89-94.
-
(2005)
Thromb Res
, vol.115
, pp. 89-94
-
-
Samara, W.M.1
Bliden, K.P.2
Tantry, U.S.3
Gurbel, P.A.4
-
16
-
-
67749117943
-
Clopidogrel response variability: Current status and future directions
-
Ferreiro JL, Angiolillo DJ. Clopidogrel response variability: current status and future directions. Thromb Haemost. 2009;102:7-14.
-
(2009)
Thromb Haemost
, vol.102
, pp. 7-14
-
-
Ferreiro, J.L.1
Angiolillo, D.J.2
-
17
-
-
0037132876
-
Bias and causal associations in observational research
-
Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359:248-252.
-
(2002)
Lancet
, vol.359
, pp. 248-252
-
-
Grimes, D.A.1
Schulz, K.F.2
-
18
-
-
33750479499
-
Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement
-
Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Buttner HJ, Neumann FJ. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol. 2006;48:1742-1750.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1742-1750
-
-
Hochholzer, W.1
Trenk, D.2
Bestehorn, H.P.3
Fischer, B.4
Valina, C.M.5
Ferenc, M.6
Gick, M.7
Caputo, A.8
Buttner, H.J.9
Neumann, F.J.10
-
19
-
-
33947517527
-
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: Results of the ARMYDA-ACS randomized trial
-
Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007;49:1272-1278.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1272-1278
-
-
Patti, G.1
Pasceri, V.2
Colonna, G.3
Miglionico, M.4
Fischetti, D.5
Sardella, G.6
Montinaro, A.7
Di Sciascio, G.8
-
20
-
-
59849120163
-
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up
-
Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation. 2009;119:237-242.
-
(2009)
Circulation
, vol.119
, pp. 237-242
-
-
Marcucci, R.1
Gori, A.M.2
Paniccia, R.3
Giusti, B.4
Valente, S.5
Giglioli, C.6
Buonamici, P.7
Antoniucci, D.8
Abbate, R.9
Gensini, G.F.10
-
21
-
-
60949083948
-
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis
-
Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849-856.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 849-856
-
-
Sibbing, D.1
Braun, S.2
Morath, T.3
Mehilli, J.4
Vogt, W.5
Schomig, A.6
Kastrati, A.7
Von Beckerath, N.8
-
22
-
-
33645982865
-
High post-treatment platelet reactivity identified lowresponders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
-
Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC. High post-treatment platelet reactivity identified lowresponders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost. 2006;4:542-549.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 542-549
-
-
Cuisset, T.1
Frere, C.2
Quilici, J.3
Barbou, F.4
Morange, P.E.5
Hovasse, T.6
Bonnet, J.L.7
Alessi, M.C.8
-
23
-
-
77249113768
-
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation
-
Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HT, Bal ET, Deneer VH, Harmsze AM, van der Heyden JAS, Rensing BJ, Suttorp MJ, Hackeng CM, ten Berg JM. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010;303:754-762.
-
(2010)
JAMA
, vol.303
, pp. 754-762
-
-
Breet, N.J.1
Van Werkum, J.W.2
Bouman, H.J.3
Kelder, J.C.4
Ruven, H.T.5
Bal, E.T.6
Deneer, V.H.7
Harmsze, A.M.8
Van Der Heyden, J.A.S.9
Rensing, B.J.10
Suttorp, M.J.11
Hackeng, C.M.12
Ten Berg, J.M.13
-
24
-
-
33846894344
-
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models
-
Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007;115:654-657.
-
(2007)
Circulation
, vol.115
, pp. 654-657
-
-
Zou, K.H.1
O'Malley, A.J.2
Mauri, L.3
-
25
-
-
44949173754
-
Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
-
Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS. Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008;29:992-1000.
-
(2008)
Eur Heart J
, vol.29
, pp. 992-1000
-
-
Price, M.J.1
Endemann, S.2
Gollapudi, R.R.3
Valencia, R.4
Stinis, C.T.5
Levisay, J.P.6
Ernst, A.7
Sawhney, N.S.8
Schatz, R.A.9
Teirstein, P.S.10
-
26
-
-
51649108832
-
Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study
-
Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol. 2008;52:1128-1133.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1128-1133
-
-
Patti, G.1
Nusca, A.2
Mangiacapra, F.3
Gatto, L.4
D'Ambrosio, A.5
Di Sciascio, G.6
-
27
-
-
35048856897
-
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
-
Frere C, Cuisset T, Quilici J, Camoin L, Carvajal J, Morange PE, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost. 2007;98:838-843.
-
(2007)
Thromb Haemost
, vol.98
, pp. 838-843
-
-
Frere, C.1
Cuisset, T.2
Quilici, J.3
Camoin, L.4
Carvajal, J.5
Morange, P.E.6
Lambert, M.7
Juhan-Vague, I.8
Bonnet, J.L.9
Alessi, M.C.10
-
28
-
-
34447636769
-
Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events
-
Bonello L, Paganelli F, Arpin-Bornet M, Auquier P, Sampol J, Dignat-George F, Barragan P, Camoin-Jau L. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost. 2007;5:1630-1636.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1630-1636
-
-
Bonello, L.1
Paganelli, F.2
Arpin-Bornet, M.3
Auquier, P.4
Sampol, J.5
Dignat-George, F.6
Barragan, P.7
Camoin-Jau, L.8
-
29
-
-
0037406216
-
Durability of platelet inhibition by clopidogrel
-
Gurbel PA, Bliden KP. Durability of platelet inhibition by clopidogrel. Am J Cardiol. 2003;91:1123-1125.
-
(2003)
Am J Cardiol
, vol.91
, pp. 1123-1125
-
-
Gurbel, P.A.1
Bliden, K.P.2
-
30
-
-
56349140778
-
The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study
-
Saw J, Madsen EH, Chan S, Maurer-Spurej E. The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study. J Am Coll Cardiol. 2008;52:1826-1833.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1826-1833
-
-
Saw, J.1
Madsen, E.H.2
Chan, S.3
Maurer-Spurej, E.4
-
31
-
-
34250020766
-
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis
-
Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;49:2312-2317.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2312-2317
-
-
Buonamici, P.1
Marcucci, R.2
Migliorini, A.3
Gensini, G.F.4
Santini, A.5
Paniccia, R.6
Moschi, G.7
Gori, A.M.8
Abbate, R.9
Antoniucci, D.10
-
32
-
-
8344221349
-
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
-
Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-3175.
-
(2004)
Circulation
, vol.109
, pp. 3171-3175
-
-
Matetzky, S.1
Shenkman, B.2
Guetta, V.3
Shechter, M.4
Bienart, R.5
Goldenberg, I.6
Novikov, I.7
Pres, H.8
Savion, N.9
Varon, D.10
Hod, H.11
-
33
-
-
33846837282
-
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: Is the current antiplatelet therapy adequate?
-
Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol. 2007;49:657-666.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 657-666
-
-
Bliden, K.P.1
Dichiara, J.2
Tantry, U.S.3
Bassi, A.K.4
Chaganti, S.K.5
Gurbel, P.A.6
-
34
-
-
38349121677
-
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment
-
Angiolillo DJ, Costa MA, Shoemaker SB, Desai B, Bernardo E, Suzuki Y, Charlton RK, Zenni MM, Guzman LA, Bass TA. Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment. Am J Cardiol. 2008;101:440-445.
-
(2008)
Am J Cardiol
, vol.101
, pp. 440-445
-
-
Angiolillo, D.J.1
Costa, M.A.2
Shoemaker, S.B.3
Desai, B.4
Bernardo, E.5
Suzuki, Y.6
Charlton, R.K.7
Zenni, M.M.8
Guzman, L.A.9
Bass, T.A.10
-
35
-
-
62549101321
-
Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: Results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients with Clopidogrel Resistance) randomized study
-
Jeong YH, Lee SW, Choi BR, Kim IS, Seo MK, Kwak CH, Hwang JY, Park SW. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study. J Am Coll Cardiol. 2009;53:1101-1109.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1101-1109
-
-
Jeong, Y.H.1
Lee, S.W.2
Choi, B.R.3
Kim, I.S.4
Seo, M.K.5
Kwak, C.H.6
Hwang, J.Y.7
Park, S.W.8
-
36
-
-
51749097093
-
Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction
-
Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. Am J Cardiol. 2008;102:524-529.
-
(2008)
Am J Cardiol
, vol.102
, pp. 524-529
-
-
Matetzky, S.1
Fefer, P.2
Shenkman, B.3
Varon, D.4
Savion, N.5
Hod, H.6
-
37
-
-
57549090390
-
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: Results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study
-
Aleil B, Jacquemin L, De Poli F, Zaehringer M, Collet JP, Montalescot G, Cazenave JP, Dickele MC, Monassier JP, Gachet C. Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. JACC Cardiovasc Interv. 2008;1:631-638.
-
(2008)
JACC Cardiovasc Interv
, vol.1
, pp. 631-638
-
-
Aleil, B.1
Jacquemin, L.2
De Poli, F.3
Zaehringer, M.4
Collet, J.P.5
Montalescot, G.6
Cazenave, J.P.7
Dickele, M.C.8
Monassier, J.P.9
Gachet, C.10
-
38
-
-
52449085759
-
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study
-
Angiolillo DJ, Capranzano P, Goto S, Aslam M, Desai B, Charlton RK, Suzuki Y, Box LC, Shoemaker SB, Zenni MM, Guzman LA, Bass TA. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. Eur Heart J. 2008;29:2202-2211.
-
(2008)
Eur Heart J
, vol.29
, pp. 2202-2211
-
-
Angiolillo, D.J.1
Capranzano, P.2
Goto, S.3
Aslam, M.4
Desai, B.5
Charlton, R.K.6
Suzuki, Y.7
Box, L.C.8
Shoemaker, S.B.9
Zenni, M.M.10
Guzman, L.A.11
Bass, T.A.12
-
39
-
-
34548497430
-
Poor responsiveness to clopidogrel: Drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study
-
Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, Federici F, Ferrari F, Tebaldi M, Luccarelli S, Parrinello G, Ferrari R. Poor responsiveness to clopidogrel: Drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol. 2007;50:1132-1137.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1132-1137
-
-
Campo, G.1
Valgimigli, M.2
Gemmati, D.3
Percoco, G.4
Catozzi, L.5
Frangione, A.6
Federici, F.7
Ferrari, F.8
Tebaldi, M.9
Luccarelli, S.10
Parrinello, G.11
Ferrari, R.12
-
40
-
-
77953700577
-
Abstract 5901: The effect of ticagrelor in stable coronary artery disease patients nonresponsive to clopidogrel: The RESPOND study
-
Gurbel P, Bliden K, Antonino M, Butler K, Teng R, Rasmussen L, Syd AS, Storey RF, Nielsen T, Eikelboom J, Sabe-Affaki G, Husted S, Kereiakes D, Henderson D, Patel DV, Tantry U. Abstract 5901: the effect of ticagrelor in stable coronary artery disease patients nonresponsive to clopidogrel: the RESPOND study. Circulation. 2009;120:S1173.
-
(2009)
Circulation
, vol.120
-
-
Gurbel, P.1
Bliden, K.2
Antonino, M.3
Butler, K.4
Teng, R.5
Rasmussen, L.6
Syd, A.S.7
Storey, R.F.8
Nielsen, T.9
Eikelboom, J.10
Sabe-Affaki, G.11
Husted, S.12
Kereiakes, D.13
Henderson, D.14
Patel, D.V.15
Tantry, U.16
-
41
-
-
67650745975
-
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study
-
Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators
-
Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabate M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R; Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study. Circulation. 2009;119:3215-3222.
-
(2009)
Circulation
, vol.119
, pp. 3215-3222
-
-
Valgimigli, M.1
Campo, G.2
De Cesare, N.3
Meliga, E.4
Vranckx, P.5
Furgieri, A.6
Angiolillo, D.J.7
Sabate, M.8
Hamon, M.9
Repetto, A.10
Colangelo, S.11
Brugaletta, S.12
Parrinello, G.13
Percoco, G.14
Ferrari, R.15
-
42
-
-
36348943475
-
Common polymorphisms of cyp2c19 and cyp2c9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
-
Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS, Lachno DR, Salazar D, Winters KJ. Common polymorphisms of cyp2c19 and cyp2c9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost. 2007;5:2429-2436.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 2429-2436
-
-
Brandt, J.T.1
Close, S.L.2
Iturria, S.J.3
Payne, C.D.4
Farid, N.A.5
Ernest, C.S.6
Lachno, D.R.7
Salazar, D.8
Winters, K.J.9
-
43
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
TRITON-TIMI 38 Investigators
-
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
Montalescot, G.4
Ruzyllo, W.5
Gottlieb, S.6
Neumann, F.J.7
Ardissino, D.8
De Servi, S.9
Murphy, S.A.10
Riesmeyer, J.11
Weerakkody, G.12
Gibson, C.M.13
Antman, E.M.14
-
44
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
Horrow, J.7
Husted, S.8
James, S.9
Katus, H.10
Mahaffey, K.W.11
Scirica, B.M.12
Skene, A.13
Steg, P.G.14
Storey, R.F.15
Harrington, R.A.16
Freij, A.17
Thorsen, M.18
-
45
-
-
34548545280
-
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction
-
note
-
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116: e148-e304.
-
(2007)
Circulation
, vol.116
-
-
Anderson, J.L.1
Adams, C.D.2
Antman, E.M.3
Bridges, C.R.4
Califf, R.M.5
Casey Jr., D.E.6
Chavey II, W.E.7
Fesmire, F.M.8
Hochman, J.S.9
Levin, T.N.10
Lincoff, A.M.11
Peterson, E.D.12
Theroux, P.13
Wenger, N.K.14
Wright, R.S.15
Smith Jr., S.C.16
Jacobs, A.K.17
Halperin, J.L.18
Hunt, S.A.19
Krumholz, H.M.20
Kushner, F.G.21
Lytle, B.W.22
Nishimura, R.23
Ornato, J.P.24
Page, R.L.25
Riegel, B.26
more..
-
46
-
-
33646732608
-
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
-
Jernberg T, Payne CD, Winters KJ, Darstein C, Brandt JT, Jakubowski JA, Naganuma H, Siegbahn A, Wallentin L. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J. 2006;27:1166-1173.
-
(2006)
Eur Heart J
, vol.27
, pp. 1166-1173
-
-
Jernberg, T.1
Payne, C.D.2
Winters, K.J.3
Darstein, C.4
Brandt, J.T.5
Jakubowski, J.A.6
Naganuma, H.7
Siegbahn, A.8
Wallentin, L.9
-
47
-
-
73949112820
-
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/ OFFSET study
-
Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/ OFFSET study. Circulation. 2009;120:2577-2585.
-
(2009)
Circulation
, vol.120
, pp. 2577-2585
-
-
Gurbel, P.A.1
Bliden, K.P.2
Butler, K.3
Tantry, U.S.4
Gesheff, T.5
Wei, C.6
Teng, R.7
Antonino, M.J.8
Patil, S.B.9
Karunakaran, A.10
Kereiakes, D.J.11
Parris, C.12
Purdy, D.13
Wilson, V.14
Ledley, G.S.15
Storey, R.F.16
-
48
-
-
74749097435
-
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement
-
Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schomig A, von Beckerath N, Kastrati A. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost. 2010;8:250-256.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 250-256
-
-
Sibbing, D.1
Schulz, S.2
Braun, S.3
Morath, T.4
Stegherr, J.5
Mehilli, J.6
Schomig, A.7
Von Beckerath, N.8
Kastrati, A.9
-
49
-
-
57549099501
-
Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: A prospective, randomized study
-
Cuisset T, Frere C, Quilici J, Morange P-E, Mouret J-P, Bali L, Moro P-J, Lambert M, Alessi M-C, Bonnet JL. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. JACC Cardiovasc Interv. 2008;1:649-653.
-
(2008)
JACC Cardiovasc Interv
, vol.1
, pp. 649-653
-
-
Cuisset, T.1
Frere, C.2
Quilici, J.3
Morange, P.-E.4
Mouret, J.-P.5
Bali, L.6
Moro, P.-J.7
Lambert, M.8
Alessi, M.-C.9
Bonnet, J.L.10
-
50
-
-
41249093357
-
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study
-
Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol. 2008;51:1404-1411.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1404-1411
-
-
Bonello, L.1
Camoin-Jau, L.2
Arques, S.3
Boyer, C.4
Panagides, D.5
Wittenberg, O.6
Simeoni, M.C.7
Barragan, P.8
Dignat-George, F.9
Paganelli, F.10
-
51
-
-
64549133799
-
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trial
-
Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. Am Heart J. 2009;157:818-824.
-
(2009)
Am Heart J
, vol.157
, pp. 818-824
-
-
Price, M.J.1
Berger, P.B.2
Angiolillo, D.J.3
Teirstein, P.S.4
Tanguay, J.F.5
Kandzari, D.E.6
Cannon, C.P.7
Topol, E.J.8
|